Typo error on such important piece of information. It’s EU’s not EC’s approval https://www.reuters.com/business/healthcare-pharmaceuticals/eu-regulator-backs-approval-covid-19-drugs-regeneron-roche-celltrion-2021-11-11/.
EC Formally Authorises COVID-19 Drugs From Regeneron-Roche, Celltrion
European Medicines Agency (EMA):Ema: The European Commission Authorised The Covid-19 Treatments Regk
Aiya.. it’s EU. Not EC.https://www.reuters.com/business/healthcare-pharmaceuticals/eu-regulator-backs-approval-covid-19-drugs-regeneron-roche-celltrion-2021-11-11/
I think Investors need to understand the difference between the 2. 1 is for prevention and the later COVID-19 pill is for treatment should the vaccined patients have got infected and identified with symptoms at early stage. (Below attached link for understanding the uses of antiviral pills)Well, it is excellent timing to grab Moderna while it is low price. Do note that Moderna has another product in the pipeline at 3rd clinical trial stage.So Go Grab it! It is real CHEAP now !!https://www.yalemedicine.org/news/9-things-to-know-about-covid-pill
Moderna’s investors panic over Merck’s antiviral pills
I think Investors need to understand the difference between the 2. 1 is for prevention and the later COVID-19 pill is for treatment should the vaccined patients have got infected and identified with symptoms at early stage. (Below attached link for understanding the uses of antiviral pills)Well, it is excellent timing to grab Moderna while it is low price. Do note that Moderna has another product in the pipeline at 3rd clinical trial stage.So Go Grab it! It is real CHEAP now !!https://www.yalemedicine.org/news/9-things-to-know-about-covid-pill
Why Regeneron Pharmaceutical share price fell on Friday?REGN 3Q earnings was outstanding. With earnings of 15.37 vs 10.10 est, revenue 3.45B vs 2.82 est. Don’t Panic. REGN is still an under value and aggressive growth stocks. Antiviral oral tablet is merly 1 of its products.